Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
909,544
-
Share change
-
-44,323
-
Total reported value
-
$53,049,217
-
Price per share
-
$58.27
-
Number of holders
-
74
-
Value change
-
-$1,578,571
-
Number of buys
-
27
-
Number of sells
-
27
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q2 2020
As of 30 Jun 2020,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
909,544 shares.
The largest 10 holders included
MORGAN STANLEY, ROYAL BANK OF CANADA, UBS Group AG, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, ADVISOR GROUP HOLDINGS, INC., Anfield Capital Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PFG Advisors, and YHB Investment Advisors, Inc..
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.